MDGL Competitors & Alternatives
Compare Madrigal Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
MDGL
Main Stock$457.96
Tradestie Score
59
Market Cap
$10.01B
Revenue Growth
0.7%
Analyst Upside
+49.6%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$238.90
|
$12.36B | 17.6 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$64.58
|
$11.09B | 20.3 | 38 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.80
|
$10.76B | - | 62 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$245.81
|
$10.74B | - | 35 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$55.21
|
$10.53B | 152.5 | 72 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$44.27
|
$10.49B | - | 69 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$67.74
|
$10.22B | - | 70 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.64
|
$9.33B | 62.6 | 59 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$116.28
|
$8.88B | 258.8 | 55 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$124.83
|
$8.77B | 35.8 | 40 | Compare |
More MDGL Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry